![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, December 30, 2021 5:51:38 PM
"SRNE. AMGEN. ENBREL & 2 SUPER BLOCKBUSTERS (SP102 / ABIVERTINIB)
Great article from BIOPHARMA DIVE about AMGEN, and Its super blockbuster drug Enbrel. Enbrel and Sorrento’s device Sofusa DoseConnect are currently part of a clinical trial.
clinicaltrials.gov/ct2/show...
Drugmakers often gauge the potential of their products by whether annual sales can eclipse $1 billion. Large pharmaceutical companies have a handful of these “blockbusters,” while successful biotechs might have one or two. SORRENTO a biotech under 2B MC has two potential super blockbusters (over 10B) in SP102 and Abivertinib (NSCLC) which should be approved in 2022. When including Abivertinib as a super blockbuster, I included it’s indications in which we should see approval or EUA (NSCLC / 5656.
https://www.biopharmadive.com/news/amgen-enbrel-patent-thicket-monopoly-biosimilar/609042/
There are many reasons to invest in SRNE. There’s been a lack of focus and mismanagement by the company, and long term manipulation by outside parties, but for those investors that do their research there are many obvious reasons this is not your normal small biotech company. For those inpatient investors remember that in 2022, and not 3-5 years down the line, there will be not one but two approvals, and a likely EUA.
We should get more SP102 data in January, and hopefully ACEA Abivertinib China approval as well. Both of these are significant, and will move the SP. Happy New Year."
"The refusal of the real is the number one dogma of our time" Rene Girard
Recent SRNE News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM
UC Asset announces plan of management stock buyback • UCASU • Sep 3, 2024 9:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM